The House Judiciary Committee will hold a hearing Thursday (July 27) on “antitrust concerns and the FDA approval process,” which one source familiar with the hearing says will deal specifically with the REMS reform bill, the Creating and Restoring Equal Access to Equivalent Samples (CREATES) Act. FDA Commissioner Scott Gottlieb will testify, as will the Federal Trade Commission's acting competition bureau chief and a number of academics. The CREATES Act would allow generic drug companies to sue brand companies for...